From my experience in other biotech stocks, the FDA approval can be a back and forth process that takes time for a device that claims health benefits. And usually there are numerous trials to provide data for approval. Is PO3 able to just adapt their tech to whatever device they choose and bring it to market? Or will it have to go through the normal hoops? If its the latter i think they should still announce any intention to get into the air purification market as it will excite the market - albeit for a brief time - but it would set the platform for next year's pandemic scare.
- Forums
- ASX - By Stock
- PO3
- Listed group unveils Stryker deal
Listed group unveils Stryker deal, page-8
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PO3 (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.078M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PO3 (ASX) Chart |
Day chart unavailable
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online